glp-1 patent Ozempic, Wegovy and Rybelsus: The patents behind Novo Nordisk's weight-loss drugs Did you know? India is

Youve hit on the most critical pointthat while the patent walls are coming down, the real moat for Indian pharma will be scaling these complex injectables to meet the massive global supply-demand gap

The detail of whats actually happening in *your* body, your muscle mass, your iron, your vitamin D, your thyroid, your hormones gets assumed rather than measured

Novo Nordisk was the pioneer--winning a 2014 FDA-approval for liraglutide (Saxenda) as an obesity treatment, formulated as a once-daily subcutaneous injection

However, if you have a specific brand preference, you can discuss it with the doctor during your consultation

Our medspa locations are physician-led and offer patients a variety of minimally and non-invasive treatments to maintain optimal skin health and beauty

For instance, in September 2025, the World Health Organization (WHO) updated its Model Lists of Essential Medicines (EML)